Phase 4 Psoriatic Arthritis (PsA) trials recruiting now

All Psoriatic Arthritis (PsA) trials, every phase

Phase 4 Psoriatic Arthritis (PsA) trials

• Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)
  NCT07611747 · Phase: Phase 4 · Ages: 50 Years and older · Sex: All (male and female) · 34 locations
• Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease
  NCT07280702 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial
  NCT07111494 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Preventing Structural Damage in Early Psoriatic Arthritis
  NCT07486843 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases
  NCT07160231 · Phase: Phase 4 · Ages: 16 Years and older · Sex: All (male and female) · 14 locations
• Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
  NCT07087912 · Phase: Phase 4 · Ages: 12 Years to 59 Years · Sex: All (male and female) · 4 locations

Common questions

What does Phase 4 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.